RU94042516A - Method of opium abstinent syndrome arresting
- Google Patents
Method of opium abstinent syndrome arresting
Info
Publication number
RU94042516A
RU94042516ARU94042516/14ARU94042516ARU94042516ARU 94042516 ARU94042516 ARU 94042516ARU 94042516/14 ARU94042516/14 ARU 94042516/14ARU 94042516 ARU94042516 ARU 94042516ARU 94042516 ARU94042516 ARU 94042516A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by С.И. ЖижилевfiledCriticalС.И. Жижилев
Priority to RU94042516ApriorityCriticalpatent/RU2131245C1/en
Publication of RU94042516ApublicationCriticalpatent/RU94042516A/en
Application grantedgrantedCritical
Publication of RU2131245C1publicationCriticalpatent/RU2131245C1/en
FIELD: medicine, narcology. SUBSTANCE: method involves intramuscular administration of complex drug consisting of 5% pentamine, 50% analgin, 1% dimedrol and relanium. Together with medicinal treatment suggestive action is carried out in patient to stop narcotic uptake. EFFECT: decreased arresting time, decreased relapse, prolonged remission.
Claims (1)
Изобретение относится к медицине, а именно к наркологии и может быть использовано для лечения больных наркоманией. Заявляемый способ включает внутримышечное введение комплекса лекарственных препаратов, в состав которых входит пентамин 5%, анальгин 50%, димедроль 1% и реланиум. Совместно с лекарственным воздействием осуществляют суггестивное, направленное на формирование у больного психологической установки на прекращение приема наркотиков. Способ позволяет сократить срок купирования абстинентного синдрома, уменьшить вероятность рецидива приема наркотиков, продлить период ремиссии.The invention relates to medicine, namely to narcology and can be used to treat patients with drug addiction. The inventive method includes intramuscular administration of a complex of drugs, which include pentamine 5%, analgin 50%, diphenhydramine 1% and relanium. Together with the drug exposure, a suggestive one is carried out, aimed at forming a patient's psychological attitude to stop taking drugs. The method allows to reduce the period of relief of withdrawal symptoms, reduce the likelihood of a relapse of drug use, extend the period of remission.
RU94042516A1994-12-051994-12-05Method of stopping opium abstinent syndrome
RU2131245C1
(en)